Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)
Primary Purpose
Amyotrophic Lateral Sclerosis
Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
telesurveillance
Sponsored by
About this trial
This is an interventional treatment trial for Amyotrophic Lateral Sclerosis focused on measuring home care, home rehabilitation, telemedicine, ALS
Eligibility Criteria
Inclusion criteria:
- 40 ALS patients (VC < 80% with or without tracheostomy)will be enrolled after discharge from Respiratory or Neurological units of S. Maugeri Foundation.
Exclusion Criteria:
- None
Sites / Locations
- Michele Vitacca
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Telesurveillance
Arm Description
At time of discharge from hospital, 40 ALS patients willbe enrolled in a telesurveillance program (TP) for the management of cought at home. Two hours of an in-hospital educational training will be provided to patients and caregivers on the use of: air stacking with Ambu balloon manual manoeuvres and in-Exoflator device indications and use
Outcomes
Primary Outcome Measures
To test a possible alternative of care for ALS patients (home vs hospital)
Secondary Outcome Measures
To check patients and caregivers' acceptance
Full Information
NCT ID
NCT00613899
First Posted
January 17, 2008
Last Updated
February 3, 2016
Sponsor
Fondazione Salvatore Maugeri
1. Study Identification
Unique Protocol Identification Number
NCT00613899
Brief Title
Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)
Official Title
Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)
Study Type
Interventional
2. Study Status
Record Verification Date
July 2011
Overall Recruitment Status
Completed
Study Start Date
October 2007 (undefined)
Primary Completion Date
March 2008 (Actual)
Study Completion Date
October 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fondazione Salvatore Maugeri
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators want to test feasibility of a structured program of telesurveillance and home cough assistance for ALS patients.
Detailed Description
Background: Amyotrophic Lateral Sclerosis (ALS) patients present reduction in the inspiratory and expiratory muscle strength, frequent secretions increase, insufficient expectoration ability with inevitable risk of acute respiratory failure (ARF) and necessity of hospitalizations. Recently, new mechanical tools (In-Exoflator EmersonR) are available in our hospital to help patients to expectorate during ARF. It is well noted these patients are particularly reluctant to be hospitalized to avoid further worsening in their quality of life.
Aim: the investigators want to test feasibility of a structured program of telesurveillance and home cough assistance for ALS patients.
Methods: A telesurveillance program (TP), a pulsed saturimetric device, 2 hours educational hospital sections (air stacking with Ambu balloon, manual manoeuvres and In-Exoflator indications and use) will be offered to all ALS consecutive patients.
In details the TP is structured as follows: 1) Domiciliary Telesurveillance by only one 24-h Service Centre (SC) for enrolled pts with ALS in hospital discharge phase, 2) Patients - taken care of five days/week by a nurse-tutor (NT) and respiratory therapist (RT) according to a predefined appointments, 3) for 24-hr. duration (in case of symptoms) patients can call SC and talk to pneumologists that can intervene whenever needed for diagnostic-therapeutic adjustments. 4) In case of need the patient can contact the neurologist or psychologist; 5) The RT in accordance with pneumologist can decide for a domiciliary visit to patient.
Home RT accesses and In-Exoflator activation will be prescribed when patients will present worsening of three points in pSaTO2, 30% in peak cough expiratory flow (PCEF), lack of cough ability with increase in secretions and or suctions necessity (in tracheotomy patients) and clinical symptoms (dyspnoea, fever, headache, somnolence).
Number of In-Ex and air stacking activations, ARF episodes, hospital accesses, antibiotic therapy, customer satisfaction, PCF/PEF, MIC-VC, respiratory function (MIP, MEP, FEV1, FVC, FEV1/FVC, ABG), dyspnoea (Borg scale), general disability (Hoevelaken scale and ALS Functional Rating Scale) and survival will be collected.
Expected results: 30 ALS patients (VC < 80% and 40% with tracheotomy) will be enrolled after discharge from Respiratory or Neurological units of S. Maugeri Foundation. This study will allow:
To test a possible alternative of care for ALS patients
To check patients and caregivers' acceptance
To measure time consuming for care team
To quantify patient's comfort
To test costs/effectiveness ratio.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amyotrophic Lateral Sclerosis
Keywords
home care, home rehabilitation, telemedicine, ALS
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Telesurveillance
Arm Type
Other
Arm Description
At time of discharge from hospital, 40 ALS patients willbe enrolled in a telesurveillance program (TP) for the management of cought at home.
Two hours of an in-hospital educational training will be provided to patients and caregivers on the use of:
air stacking with Ambu balloon
manual manoeuvres and
in-Exoflator device indications and use
Intervention Type
Other
Intervention Name(s)
telesurveillance
Other Intervention Name(s)
telemedicine
Intervention Description
A telesurveillance program for cough assistance will be approched by the use of an in-exoflator device. Measurement of oxygen saturation (SpO2) will be performed by a Nonin 9500 oxymeter (Minneapolis Plymouth USA).
Primary Outcome Measure Information:
Title
To test a possible alternative of care for ALS patients (home vs hospital)
Time Frame
6-12 months
Secondary Outcome Measure Information:
Title
To check patients and caregivers' acceptance
Time Frame
6-12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
40 ALS patients (VC < 80% with or without tracheostomy)will be enrolled after discharge from Respiratory or Neurological units of S. Maugeri Foundation.
Exclusion Criteria:
None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
michele vitacca, MD
Organizational Affiliation
FSM IRCCS Lumezzane
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
michele vitacca, MD
Organizational Affiliation
FSM IRCCS LUmezzane (BS) ITALY
Official's Role
Principal Investigator
Facility Information:
Facility Name
Michele Vitacca
City
Lumezzane
State/Province
BS
ZIP/Postal Code
25065
Country
Italy
12. IPD Sharing Statement
Citations:
PubMed Identifier
15078752
Citation
Sancho J, Servera E, Diaz J, Marin J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest. 2004 Apr;125(4):1400-5. doi: 10.1378/chest.125.4.1400.
Results Reference
background
PubMed Identifier
20407305
Citation
Vitacca M, Paneroni M, Trainini D, Bianchi L, Assoni G, Saleri M, Gile S, Winck JC, Goncalves MR. At home and on demand mechanical cough assistance program for patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2010 May;89(5):401-6. doi: 10.1097/PHM.0b013e3181d89760.
Results Reference
result
PubMed Identifier
24491372
Citation
Paneroni M, Trainini D, Winck JC, Vitacca M. Pilot study for home monitoring of cough capacity in amyotrophic lateral sclerosis: A case series. Rev Port Pneumol. 2014 Jul-Aug;20(4):181-7. doi: 10.1016/j.rppneu.2013.11.003. Epub 2014 Feb 1.
Results Reference
derived
Links:
URL
http://www.aisla.it
Description
association of amyotrophic lateral sclerosis patients
Learn more about this trial
Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)
We'll reach out to this number within 24 hrs